Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/4/17 → 9/30/19 |
Funding
- Mallinckrodt ARD Incorporated: $25,680.00
MNK14042068: A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
- Kasarskis, Edward (PI)